USANA Health Sciences Inc
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essen… Read more
USANA Health Sciences Inc (USNA) - Total Assets
Latest total assets as of September 2025: $726.59 Million USD
Based on the latest financial reports, USANA Health Sciences Inc (USNA) holds total assets worth $726.59 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
USANA Health Sciences Inc - Total Assets Trend (1995–2024)
This chart illustrates how USANA Health Sciences Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
USANA Health Sciences Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
USANA Health Sciences Inc's total assets of $726.59 Million consist of 37.3% current assets and 62.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 24.3% |
| Accounts Receivable | $8.22 Million | 1.1% |
| Inventory | $69.73 Million | 9.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $151.82 Million | 20.3% |
| Goodwill | $144.17 Million | 19.3% |
Asset Composition Trend (1995–2024)
This chart illustrates how USANA Health Sciences Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: USANA Health Sciences Inc's current assets represent 37.3% of total assets in 2024, a decrease from 52.9% in 1995.
- Cash Position: Cash and equivalents constituted 24.3% of total assets in 2024, down from 29.4% in 1995.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 39.0% of total assets, an increase from 0.0% in 1995.
- Asset Diversification: The largest asset category is intangible assets at 20.3% of total assets.
USANA Health Sciences Inc Competitors by Total Assets
Key competitors of USANA Health Sciences Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
Maniker F & G Co. Ltd
KQ:195500
|
Korea | ₩123.42 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
|
Xinjiang Chalkis Co Ltd
SHE:000972
|
China | CN¥1.25 Billion |
|
Daehan Flour Mills Co Ltd
KO:001130
|
Korea | ₩1.61 Trillion |
USANA Health Sciences Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - USANA Health Sciences Inc generates 1.14x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, USANA Health Sciences Inc generates $5.62 in net profit.
USANA Health Sciences Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.23 | 3.93 | 2.52 |
| Quick Ratio | 1.46 | 3.37 | 1.98 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $145.40 Million | $ 336.41 Million | $ 255.14 Million |
USANA Health Sciences Inc - Advanced Valuation Insights
This section examines the relationship between USANA Health Sciences Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.73 |
| Latest Market Cap to Assets Ratio | 0.23 |
| Asset Growth Rate (YoY) | 18.2% |
| Total Assets | $748.19 Million |
| Market Capitalization | $169.73 Million USD |
Valuation Analysis
Below Book Valuation: The market values USANA Health Sciences Inc's assets below their book value (0.23 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: USANA Health Sciences Inc's assets grew by 18.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for USANA Health Sciences Inc (1995–2024)
The table below shows the annual total assets of USANA Health Sciences Inc from 1995 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $748.19 Million | +18.24% |
| 2023-12-31 | $632.76 Million | +6.07% |
| 2022-12-31 | $596.55 Million | +3.26% |
| 2021-12-31 | $577.74 Million | -9.85% |
| 2020-12-31 | $640.89 Million | +23.98% |
| 2019-12-31 | $516.93 Million | -6.77% |
| 2018-12-31 | $554.46 Million | +6.78% |
| 2017-12-31 | $519.27 Million | +10.33% |
| 2016-12-31 | $470.64 Million | +11.20% |
| 2015-12-31 | $423.24 Million | +20.72% |
| 2014-12-31 | $350.58 Million | -4.85% |
| 2013-12-31 | $368.47 Million | +37.82% |
| 2012-12-31 | $267.36 Million | +9.35% |
| 2011-12-31 | $244.50 Million | +19.97% |
| 2010-12-31 | $203.80 Million | +65.10% |
| 2009-12-31 | $123.44 Million | +0.71% |
| 2008-12-31 | $122.57 Million | +12.32% |
| 2007-12-31 | $109.13 Million | +9.13% |
| 2006-12-31 | $100.00 Million | +35.67% |
| 2005-12-31 | $73.71 Million | +2.85% |
| 2004-12-31 | $71.66 Million | +10.04% |
| 2003-12-31 | $65.13 Million | +66.51% |
| 2002-12-31 | $39.11 Million | +10.63% |
| 2001-12-31 | $35.35 Million | -0.39% |
| 2000-12-31 | $35.49 Million | -3.55% |
| 1999-12-31 | $36.80 Million | -8.00% |
| 1998-12-31 | $40.00 Million | +51.52% |
| 1997-12-31 | $26.40 Million | +25.12% |
| 1996-12-31 | $21.10 Million | +106.86% |
| 1995-12-31 | $10.20 Million | -- |